강진참사랑의료원

비상장계속사업자

kangjinchamsalasng

공관식

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

강진참사랑의료원

Business Reg. No. 1388150779 · CEO 공관식

I.Investment Overview

Target강진참사랑의료원 (1388150779)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명강진참사랑의료원
영문명kangjinchamsalasng
대표자공관식
사업자등록번호1388150779
법인등록번호1341110173679
설립일2009.01.12

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW16.3202117.4202219.5202318.8202417.92025
영업이익100M KRW8.720219.3202211.1202310.120249.12025
순이익100M KRW-1.92021-1.72022-1.62023-1.620241.42025
Item20252024202320222021
자산총계176.2억원196.7억원214.1억원234.7억원253.3억원
부채총계164.8억원183.9억원199.6억원218.7억원235.6억원
자본총계11.4억원12.8억원14.4억원16억원17.7억원
매출액17.9억원18.8억원19.5억원17.4억원16.3억원
영업이익9.1억원10.1억원11.1억원9.3억원8.7억원
순이익1.4억원-1.6억원-1.6억원-1.7억원-1.9억원

VI.Financial Ratios

FY2025 basis

50.91%

영업이익률

7.88%

순이익률

0.8%

ROA

12.4%

ROE

1,448.79%

부채비율

6.46%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

강진참사랑의료원 투심보고서 | Alpha Lenz